Bellicum Balance Sheet - Annual (NASDAQ:BLCM)

Add to My Stocks
$6.12 $0.14 (2.24%) BLCM stock closing price Sep 21, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Bellicum stock analysis. As in our Bellicum stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. A company releases its balance sheet every year along with its annual results. Bellicum balance sheet indicates an asset turnover ratio of 0.01 and debt to equity ratio of 0.32. Also check Bellicum revenue and Bellicum operating cash flow for the same period.

View latest 10 year balance sheet data to check Bellicum financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Cash38.83M33.14M70.24M191.6M11.16M1.63M
Marketable Securities60.05M70.63M23.82M---
Receivables------
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets2.43M1.5M2.38M1.32M--
Total Current Assets
101.65M105.61M96.89M193.22M12.16M2.47M
Property Plant & Equipment34.23M21.25M9.4M3.83M--
Accumulated Depreciation8.29M4.74M2.52M1.41M--
Net Property Plant & Equipment
25.94M16.5M6.88M2.42M2.28M2.51M
Investment & Advances1.36M-56.3M---
Other Non-Current Assets------
Deferred Charges------
Intangibles------
Deposits & Other Assets6.56M9.92M----
Total Assets
135.52M132.03M160.4M195.79M14.94M5.18M
Notes Payable------
Accounts Payable3.28M3.62M2.1M1.2M--
Current Portion Long-Term Debt-1.78M----
Current Portion Capital Leases------
Accrued Expenses6.39M9.36M5.08M2.16M1.13M-
Income Taxes Payable------
Other Current Liabilities2.44M----1.14M
Total Current Liabilities
12.15M15.11M7.44M3.63M2.2M2.22M
Mortgages------
Deferred Taxes/Income2.05M-----
Convertible Debt------
Long-Term Debt34.94M18.43M----
Non-Current Capital Leases------
Other Long-Term Liabilities1.59M1.77M----
Total Liabilities
50.88M35.46M8.38M4.15M3.16M3M
Minority Interest------
Preferred Stock----39.92M21.65M
Common Stock Net------
Capital Surplus411.92M332.06M318.59M309.36M-1.51M
Retained Earnings-322.51M-230.73M-161.49M-112.94M-28.97M-21.01M
Treasury Stock5.05M5.05M5.05M5.05M--
Other Liabilities-0.04M--0.3M---
Shareholders Equity84.64M96.57M152.01M191.63M11.77M2.18M
Total Liabilities & Shareholders Equity135.52M132.03M160.4M195.79M14.94M5.18M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Bellicum stock price, and Bellicum historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Bellicum PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Bellicum owns and has monetary significance. BLCM assets grew from $132.03M in 2016 to $135.52M in 2017. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Bellicum's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for BLCM stock stand at $50.88M.

Bellicum Balance Sheet - Key Ratios

Current ratio
10.23
Debt to equity ratio
0.32
Asset turnover ratio
0.01
Receivables turnover
1.58
Price to book ratio
2.54

Annual Balance Sheets For Bellicum Pharmaceuticals Inc Peers

Cellectis balance sheet, GlobeImmune balance sheet, Marinus Pharma balance sheet, Pfizer balance sheet